Bayer's Aflibercept injection gets DCGI nod for Diabetic Macular Edema indication

Diabetic Macular Edema occurs when high blood sugar levels damage capillaries that leak fluid into the retina, resulting in swelling and blurred vision. The approval of Aflibercept injection for intravitreal use presents a new and alternative treatment option to currently available therapies, for patients with DME, Bayer in India said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3cpzxqn
via IFTTT